Back

Endogenous intronic RNA tightly controls Cas9/CRISPR-mediated gene editing in human cells

Carneiro, A. L.; Proenca, J. T.; Valiollahi, E.; Barreto, V. M.

2026-03-25 synthetic biology
10.64898/2026.03.24.714022 bioRxiv
Show abstract

In gene editing, CRISPR/Cas approaches are often limited by off-target effects. In in vivo approaches involving multiple cell types, off-targets may result from unintended targeting of the wrong cells. In this work, we propose a solution to this limitation by using a transcribed intron of the target gene as an endogenous trigger (intron triggers) for a novel conditional guide RNA (intcgRNA). In vitro, intcgRNAs were responsive to the presence of the trigger. As a proof-of-concept, the human IL2 receptor subunit gamma gene (IL2RG) was then targeted using both the intcgRNA and the corresponding conventional crRNA in two cell lines: the lymphocytic HPB-ALL cell line, where IL2RG is highly expressed, and the epithelial HeLa cell line, where it is not. Sanger sequencing revealed that the crRNA and intcgRNA Cas9 complexes edited IL2RG with similar efficiency in HPB-ALL, whereas only the crRNA edited IL2RG in HeLa. This shows that intcgRNA avoids targeting unwanted cells that do not express the target gene, which is particularly relevant for in vivo targeting. The triggers of choice for conditional guides have been microRNAs, but as short intronic RNAs are far more diverse, trigger introns could become biomarkers of cell identity that improve the precision of CRISPR-based manipulations in vivo. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=83 SRC="FIGDIR/small/714022v1_ufig1.gif" ALT="Figure 1"> View larger version (17K): org.highwire.dtl.DTLVardef@1ae60cdorg.highwire.dtl.DTLVardef@1556c03org.highwire.dtl.DTLVardef@1264a0dorg.highwire.dtl.DTLVardef@c7d47d_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nucleic Acids Research
1128 papers in training set
Top 1%
12.9%
2
Nature Communications
4913 papers in training set
Top 13%
12.9%
3
iScience
1063 papers in training set
Top 0.9%
6.9%
4
ACS Synthetic Biology
256 papers in training set
Top 0.7%
4.9%
5
The CRISPR Journal
33 papers in training set
Top 0.1%
4.4%
6
eLife
5422 papers in training set
Top 22%
4.0%
7
Cell Reports Methods
141 papers in training set
Top 1%
2.8%
8
Advanced Science
249 papers in training set
Top 7%
2.6%
50% of probability mass above
9
Cell Genomics
162 papers in training set
Top 2%
2.4%
10
Nature Chemical Biology
104 papers in training set
Top 1%
2.1%
11
Computational and Structural Biotechnology Journal
216 papers in training set
Top 4%
1.8%
12
Cell Chemical Biology
81 papers in training set
Top 1%
1.8%
13
Molecular Therapy
71 papers in training set
Top 1%
1.7%
14
ACS Omega
90 papers in training set
Top 2%
1.7%
15
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.1%
1.5%
16
Molecular Therapy Nucleic Acids
32 papers in training set
Top 0.4%
1.4%
17
ACS Chemical Biology
150 papers in training set
Top 1%
1.4%
18
Cell Discovery
54 papers in training set
Top 3%
1.4%
19
International Journal of Molecular Sciences
453 papers in training set
Top 10%
1.2%
20
ChemBioChem
50 papers in training set
Top 0.8%
1.2%
21
Science China Life Sciences
26 papers in training set
Top 1%
1.2%
22
Communications Biology
886 papers in training set
Top 14%
1.2%
23
Frontiers in Bioengineering and Biotechnology
88 papers in training set
Top 2%
1.0%
24
RNA
169 papers in training set
Top 0.3%
1.0%
25
Journal of the American Chemical Society
199 papers in training set
Top 4%
0.9%
26
Life Science Alliance
263 papers in training set
Top 1.0%
0.9%
27
Scientific Reports
3102 papers in training set
Top 70%
0.9%
28
Journal of Molecular Biology
217 papers in training set
Top 3%
0.8%
29
Protein & Cell
25 papers in training set
Top 2%
0.8%
30
Cell
370 papers in training set
Top 16%
0.8%